ELQ SA
F:7DP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ELQ SA
F:7DP
|
PL |
|
T
|
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7DP's stock price target?
Not Available
7DP does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for ELQ SA?
Projected CAGR
486%
Over the last 14 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 1 year is 486%.
What is the Operating Income forecast for ELQ SA?
Projected CAGR
754%
Over the last 14 years, the compound annual growth rate for Operating Income has been 32%. The projected CAGR for the next 1 year is 754%.
What is the Net Income forecast for ELQ SA?
Projected CAGR
1 009%
Over the last 14 years, the compound annual growth rate for Net Income has been 34%. The projected CAGR for the next 1 year is 1 009%.
